Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
International non-controlled study of FIBRINOGENE T-I in peri-operative prophylaxis for afibrinogenaemia or severe hypofibrinogenaemia
2007-001280-30Phase 2Completed
- Sponsor
- LFB Group
- Start
- May 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Fibrinogen human in congenital afibrinogenemia and hypofibrinogenemia, sponsored by LFB Group. Started May 2007; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
congenital afibrinogenemiahypofibrinogenemia
Beyond the preview
Go deeper on 2007-001280-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001280-30.